The credibility of the FDA

Abstract

Get full access to this article

View all access options for this article.

References

Bombardier

Lanine

Reicin

. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000; 343: 1520–1528.

Lewington

Clarke

Qizilbash

. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913.

D'Agostino

Sr Vasan

Pencina

. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743–753.

Blankfield

. Blood pressure, fluid retention and the cardiovascular risk of drugs. Future Cardiology 2012; 8: 489–493.

Food and Drink Administration. Guidance for Industry: Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes. Silver Spring: FDA. Available at: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071627.pdf (2008, accessed July 2013).

Cooper

Habel

Sox

. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 2011; 365: 1896–1904.

Habel

Cooper

Sox

. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 2011; 306: 2673–2683.